27
panel
Stablecoins: A Conversation with Industry Experts
Amid the bitcoin frenzy and a pandemic-driven move to cashless payments, digital currencies have
gone from wonky curiosity to mainstream phenomenon.
+ Read More
staff
Paul Irving
Paul Irving is a corporate and nonprofit director and senior advisor to leaders in business, inve
stment, philanthropy, and academia.
+ Read More
landing page
Milken Institute Virtual Forums
Overview
The Milken Institute Virtual Forums invite our network of thought-leaders and experts to t
ackle a range of critical issues, many stemming from the effects of COVID-19.
+ Read More
panel
Lessons Learned: Examining the Philanthropic Response to COVID-19
According to the Center for Disaster Philanthropy, philanthropists from around the world respond
ed to COVID at levels that were orders of magnitude higher than any other human crisis.
+ Read More
panel
Diabetes and Obesity: An Urgent Global Health Crisis
Despite many treatments and technological advances, the health of the US and global populations
continues to decline. Chronic disease continues to increase and have a detrimental effect on personal health and health-care costs.
+ Read More
panel
Housing Finance Reform: Will We Finally Get the Stone Up the Hill?
After a decade of debate, the post-crisis US housing finance system seems poised for major refor
m. What needs to change and why? Who has the power to decide and act? Will change be incremental or far-reaching and what will drive the answer?
+ Read More
panel
Stand in Your Power: The Mindful Way
Mindfulness practices are proliferating across a range of fields and institutions, both domestic
ally and globally.
+ Read More
panel
COVID-19 and the Future of Aging
The COVID-19 pandemic has revealed health, social, and racial divides, and exposed negative perc
eptions of the value of older adults and their roles in a multi-generational society.
+ Read More
panel
The Give and Take of Drug Pricing Reform
Several proposals to lower drug costs have been introduced in recent years in response to growin
g public concern about drug prices and affordability.
+ Read More
panel
How Should We Value a Cure?
In the landscape of new, potentially curative cell and gene therapies, many uncertainties remain
including how to pay for them.
+ Read More
panel
It's the Life in Your Years: Reimagining Retirement for Longer, Healthier Lives
Advances in public health and bioscience have added decades to average lifespans over the past c
entury. But the way we plan has not met the moment.
+ Read More